Experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), is mediated by autoantigen-specific Thelper1 (Th1) cells. IL-12, an inducer of Th1 cell development, exerts immunomodulatory effects in EAE. Programmed death-1 (PD-1) and PD-1 ligand (PD-L), new members of the B7 superfamily of costimulatory molecules, play a critical role in regulating EAE. Whether the interaction of IL-12 and the PD-1/PD-L pathway regulates EAE is unclear. We have previously shown that IL-12 suppresses EAE induced by MOG35-55 in C57BL/6 mice, but not in IFN-γ-deficient mice, suggesting that IFN-γ is required for the inhibitory effects of IL-12 on EAE. In the current study, PD-L1 expression is up-regulated following IL-12 treatment in wild-type mice, but not in IFN-(-deficient EAE mice. Similarly, IL-12 induces IFN-γ and PD-L1 expression in cultured MOG-specific T cells from wild-type mice but not from IFN-γ-deficient mice. Furthermore, PD-L1 expression increased specifically in CD11b+ antigen presenting cells (APCs) after IL-12 administration. These data suggest that one mechanism of IL-12 suppression of EAE is mediated by PD-1/PD-L signaling downstream of IFN-γ induction in CD11b+ APCs. The regulation of PD-1/PD-L1 may have potential therapeutic effects for EAE and MS.
Introduction
Experimental autoimmune encephalomyelitis (EAE) is a T cell dependent autoimmune disease in the central nervous system that is used as a model for the human inflammatory demyelination mediated neurodegenerative disease, multiple sclerosis (MS) (Wekerle et al., 1994) . EAE is mediated by CD4+ T-helper1 (Th1) cells following immunization with myelin protein antigens. An important aspect of the pathogenesis of EAE, with potential for therapeutic intervention, is the role of cytokines in the inflammatory process (Begolka et al., 1998; Steinman, 1999) . Interleukin-12 (IL-12), a heterodimeric cytokine produced by activated antigen presenting cells (APCs), is a secreted protein with diverse roles in cellular differentiation and is especially important in regulating immune responses (Trinchieri et al., 2003) . IL-12 is composed of a 40 KDa heavy chain (p40) and a 35 KDa light chain (p35) (Kobayashi et al., 1989) . The major stimulus for its production is the interaction of CD40 ligand on T cells with CD40 on APCs (Gately et al., 1991) . IL-12 regulates the development of naïve CD4+ T cells to either Th1 or Th2 cells, which is a crucial event for effective acquired immunity. IL-12 promotes the growth and cytotoxicity of natural killer (NK) cells and the activation of macrophages by stimulating IFN-γ secretion (Trinchieri and Scott, 1995) . Th1 cells produce IFN-γ and promote cell-mediated immunity essential for the response against intracellular pathogens, viruses and bacteria, and IL-12 is the main cytokine that regulates Th1 differentiation (Mullen et al., 2001) .
IL-12 has been considered an important factor in the pathogenesis of MS (Gran et al., 2004a,b) . However, IL-12 is
